The Ragon Institute of Mass General, MIT, and Harvard was officially established in Cambridge, Massachusetts in 2009, with a donation from the Phillip T. And Susan M. Ragon Foundation. Our mission is to harness the immune system to prevent and cure human disease. Though we started with a focus on HIV, our scope has since grown to include six research priority areas: HIV/AIDS, Global Infectious Diseases, Emerging Infectious Diseases, Vaccine Development, Basic and Applied Immunology, and Clinical Studies.
In response to the ongoing pandemic, we have also included an Emergency Priority Area: COVID-19. Our strength is in the people we bring together to represent wide-ranging areas of expertise and the unparalleled excellence of our member organizations: the Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University.
The Ragon Institute begins a multipronged approach towards understanding, treating, and preventing infections of the new human coronavirus SARS-CoV-2.
The Ragon Institute of Mass General, MIT, and Harvard brings together scientists and engineers from diverse fields to better understand the immune system and support human health.
The Administrative and Operations team manages the Ragon’s operations, administrative, and logistical functions.
The Ragon’s clinical research focuses on clinical studies in infectious diseases such as HIV and COVID-19.